PRIME CAR-T cell (CD19 and CD22 targeted)

CD19/CD22 targeted PRIME CAR-T · Chongqing Precision Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRIME CAR-T cell (CD19 and CD22 targeted), covering 2023-04-18 to 2023-04-18. Get the full timeline:

Most recent: Clinical Trial Update: a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell Lymphoma [Phase 1, Phase 2]

See pricing